Consistent with these findings, our western blot analyses of drug resistant TNBC tumor lysates in Fig. 4C and D show that Nos followed by DTX treatment inhibited the resistance marker MDR 1 (ABCB1) in drug-resistant TNBC cells. This evidence concerns the gene ABCB1 and neoplasm.